基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 氯西加酮 氯西加酮
  • 氯西加酮|T27845|TargetMol

氯西加酮|T27845|TargetMol

Losigamone
112856-44-7
￥530 1mg 起订
￥1250 5mg 起订
￥1860 10mg 起订
上海 更新日期：2024-09-29

TargetMol中国（陶术生物）

VIP1年
联系人：邵小姐
手机：15002134094 拨打
邮箱：marketing@targetmol.cn

产品详情:

中文名称：
氯西加酮
英文名称：
Losigamone
CAS号：
112856-44-7
品牌：
TargetMol
产地：
美国
保存条件：
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格：
100%
产品类别：
抑制剂
货号：
T27845

Product Introduction

Bioactivity

名称Losigamone
描述Losigamone (AO-33) is an agonist of GABA receptor and can be used in studies about the treatment of partial seizures.
体内活性Losigamone (AO-33) was tested in 52 healthy male volunteers in 4 placebo-controlled phase I studies. In the study 1 single dose of 100, 200, 300, 500, 700, and 1,000 mg losigamone was given as a fast-releasing capsule to 12 subjects. The pharmacokinetics of losigamone measured after administration of 100, 300, and 700 mg was linear. Clearance and t1/2 were about 350 ml/min and 4 h, respectively, the Cmax values of 0.7, 1.7, and 4.4 micrograms/ml were reached after 2.5 h. In study, 2,500 mg losigamone was given as a fast-release capsule for 6 days (t.i.d.) to 12 subjects. There was a small but statistically significant decrease for the AUC but no change in t1/2, Cmax, or tmax comparing single dose kinetics on days 1 and 8. There appeared to be no change in caffeine clearance on days 1 and 9. Study 2 was repeated in 20 volunteers with a film-coated tablet. Pharmacokinetic parameters appeared to be unaffected by this change in galenical formulation. In the study 4 daily doses of 400, 1,200, and 1,800 mg losigamone were given 28 days to 24 subjects. The kinetics of caffeine and antipyrine were compared on days 1 and 29. With the exception of t1/2 for antipyrine in the 400 mg group there was no statistically significant change in pharmacokinetic parameters. Generally, losigamone was well tolerated and no serious adverse side effects occurred. In some subjects, a reversible increase in transaminases was observed.[1]
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
关键字ADD137022 | Losigamone
相关产品p-Hydroxybenzaldehyde | Penicillin G sodium salt | Valproic acid sodium salt | Valproic Acid | DL-Menthol | (-)-α-Pinene | Nikethamide | Riluzole | Chlorothymol | Piperazine citrate | Halothane | Gabapentin
相关库经典已知活性库 | 已知活性化合物库 | 神经递质受体化合物库 | 离子通道库 | 膜蛋白靶向化合物库 | 疼痛相关化合物库
氯西加酮|||AO-33|||AO33|||AO 33|||ADD137022;Losigamone|||ADD-137022|||ADD 137022|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期 (12年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ￥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,天然产物,生物化工,化学试剂,生物技术服务

氯西加酮相关厂家报价

内容声明
official 进入官方账号
拨打电话 立即询价